Effects of metrifonate on escape and avoidance learning in young and aged rats

Behavioural Pharmacology

Volumn 7, Issue 1, 1996, Pages 56-64

  Van Der Staay, F J ^a   Hinz, V C ^a   Schmidt, B H ^a  

^a Institute for Neurobiology   (Germany)

Author keywords

Cognition enhancer; Learning; Memory; Metrifonate; Morris maze; Rat; Shuttlebox

Indexed keywords

CHOLINESTERASE INHIBITOR; METRIFONATE;

AGE; AGED; ANIMAL EXPERIMENT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; ESCAPE BEHAVIOR; FACILITATION; LEARNING; MALE; MEMORY; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SWIMMING;

EID: 0030061097     PISSN: 09558810     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008877-199601000-00005     Document Type: Article

References (36)

1. Aden Abdi Y and Villén T (1991) Pharmacokinetics of metrifonate and its rearrangement product dichlorvos in whole blood. Pharmacology and Toxicology, 68, 137-139.
2. Barnes CA (1988) Spatial learning and memory processes: the search for their neurobiological mechanisms in the rat. Trends in Neuroscience, 11, 163-169.
3. Bartus RT, Dean RL III, Beer B and Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science, 217, 408-417.
4. Becker RE and Giacobini E (1988) Mechanisms of cholinesterase inhibition in senile dementia of the Alzheimer type: clinical, pharmacological, and therapeutic aspects. Drug Development Research, 12, 163-195.
5. Becker RE, Colliver J, Elble R, Feldman E, Giacobini E, Kumar V, Markwell S, Moriearty P, Parks R, Shillcutt SD, Unni L, Vicari S, Womack C and Zec RF (1990) Effects of metrifonate, a long-acting cholinesterase inhibitor, in Alzheimer disease: report of an open trial. Drug Development Research, 19, 425-434.
6. Blokland A, Hinz V, Gebert I, Armah B, van der Staay FJ and Schmidt BH (1995) Effects of metrifonate and tacrine in the spatial Morris maze task and modified Irwin test: evaluation of the efficacy/safety ratio in rats. Proceedings of the British Pharmacological Society, July 12-14, Oxford, UK, abstract no. P64.
7. Chan PC and Peters AC (1989) Thirteen week subchronic feed study on trichlorfon in Fischer rats and B6C3F1 mice. Proceedings of the American Association of Cancer Research, 30, 137-144.
8. Dixon WJ (1959a) Analyses of extreme values. Annals of Mathematical Statistics, 21, 488-506.
9. Dixon WJ (1959b) Ratios involving extreme values. Annals of Mathematical Statistics, 22, 68-78.
10. Dubois KP and Cotter GJ (1955) Studies on the toxicity and mechanism of action of dipterex. Archives of Industrial Health, 11, 53-60.
11. Freund RJ and Littell RC (1985) SAS for Linear Models: A Guide to the ANOVA and GLM Procedures. SAS Institute Inc., Cary, NC.
12. Gamzu E (1985) Animal behavioral models in the discovery of compounds to treat memory dysfunction. In: Memory Dysfunctions: An Integration of Animal and Human Research from Preclinical and Clinical Perspectives (Eds DS Olton, E Gamzu and S Corkin), Annals of the New York Academy of Sciences, 444, 370-393.
13. Giacobini E (1990) The cholinergic system in Alzheimer disease. Progress in Brain Research, 84, 321-332.
14. Growdon JH (1979) Neurotransmitter precursors in the diet: their use in the treatment of brain diseases. In: Nutrition and the Brain (Eds RJ Wurtman and JJ Wurtman), Volume 3, pp. 117-181. Raven Press, New York.
15. Hallak M and Giacobini E (1987) A comparison of the effects of two inhibitors on brain cholinesterase. Neuropharmacology, 26, 521-530.
16. Hallak M and Giacobini E (1989) Physostigmine, tacrine and metrifonate: the effect of multiple doses on acetylcholine metabolism in rat brain. Neuropharmacology, 28, 199-206.
17. Hinz V, Grewig S and Schmidt B (1995) Effects of metrifonate and its hydrolytic degradation product dichlorvos on cholinesterase activity in rat brain, erythrocytes, and plasma after single oral administration. Abstract Book of the 9th International Symposium on Cholinergic Mechanisms, June 7-10, Mainz, Germany, poster no. 77.
18. Holmstedt B, Nordgren I, Sandoz M and Sundwall A (1978) Metrifonate. Summary of toxicological and pharmacological information available. Archives of Toxicology, 41, 3-29.
19. Jaen JC and Davis RE (1993) Cholinergic therapies for Alzheimer's disease: acetylcholinesterase inhibitors of current clin-ical interest. Current Opinion in Investigational Drugs, 2, 363-377.
20. Katzman R (1986) Alzheimer's disease. The New England Journal of Medicine, 314, 964-973.
21. Mori F, Cuadra G and Giacobini E (1995) Metrifonate effects on acetylcholine and biogenic amines in rat cortex. Neurochemical Research, 20, 1081-1088.
22. Morris RGM (1984) Development of a water-maze procedure for studying spatial learning in the rat. Journal of Neuroscience Methods, 11, 47-60.
23. Mundy WR, Barone S and Tilson HA (1990) Neurotoxic lesions of the nucleus basalis induced by colchicine: effects on spatial navigation in the water maze. Brain Research, 512, 221-228.
24. Nordgren I, Bergstöm M, Holmstedt B and Sandoz M (1978) Transformation and action of Metrifonate. Archives of Toxicology, 41, 31-41.
25. Nordgren I, Karlén B and Kimland M (1992) Metrifonate and tacrine: a comparative study on their effect on acetylcholine dynamics in mouse brain. Pharmacology and Toxicology, 71, 236-240.
26. Perry EK (1980) The cholinergic system in old age and Alzheimer's disease. Age and Ageing, 9, 1-8.
27. Pomponi M, Giacobini E and Brufani M (1990) Present state and future development of the therapy of Alzheimer disease. Aging, 2, 125-153.
28. Reiner E, Krauthacker B, Simeon V and Škrinjaric-Špoljar M (1975) Mechanisms of inhibition in vitro of mammalian acetylcholinesterase and cholinesterase in solutions of 0,0-dimethyl-2,2,2-trichloro-1-hydroxyethyl phosphonate (Trichlorphon). Biochemical Pharmacology, 24, 717-722.
29. Reiner E and Pleština R (1979) Regeneration of cholinesterase activities in humans and rats after inhibition of 0,0-dimethyl-2,2-dichlorovinyl phosphate. Toxicology and Applied Pharmacology, 49, 451-454.
30. Schwarz RD, Davis RE, Gracon S, Hoover T, Moos WH and Pavia MR (1991) Next generation tacrine. Neurobiology of Aging, 12, 185-187.
31. Soininen H, Unni L and Shillcutt S (1990) Effects of acute and chronic cholinesterase inhibition on biogenic amines in rat brain. Neurochemical Research, 15, 1185-1190.
32. Unni LK, Hannant ME and Becker RE (1992) High-performance liquid chromatographic method using ultraviolet detection for measuring metrifonate and dichlorvos levels in human plasma. Journal of Chromatography, 573, 99-103.
33. van der Staay FJ and de Jonge M (1993) Effects of age on water escape behavior and on repeated acquisition in rats. Behavioral and Neural Biology, 60, 33-41.
34. Weinstock M, Razin M, Chorev M and Tashma Z (1986) Pharmacological activity of novel anticholinesterase agents of potential use in the treatment of Alzheimer's disease. In: Alzheimer's and Parkinsons Diseases: Strategies for Research and Development (Eds A Fisher, I Hanin and C Lachman). Advances in Behavioral Biology, Vol 29, pp. 539-549. Plenum Press, New York.
35. Wenk GL and Olton DS (1989) Cognitive enhancers: potential strategies and experimental results. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 13, S117-S139.
36. Wolthuis OL, Groen B, Busker RW and van Helden HPM (1995) Effects of low doses of cholinesterase inhibitors on behavioral performance of robot-tested marmosets. Pharmacology Biochemistry and Behavior, 51, 443-456.